Johnson Yiu Nam Lau serves as Executive at Chelsea Therapeutics International, Ltd., where they oversee executive responsibilities. Since joining the company, Johnson Yiu Nam Lau has executed 107 insider transactions totaling $3.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 26, 2018 involved purchasing 12,500 shares valued at $184.5K.
Johnson Yiu Nam Lau currently holds 250,397 shares of Chelsea Therapeutics International, Ltd. (CHTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Johnson Yiu Nam Lau has been a net buyer of CHTP stock. They have purchased $3.4M and sold $0 worth of shares.
Johnson Yiu Nam Lau's most recent insider trade was on Mar 26, 2018, when they purchased 12,500 shares at $14.76 per share.
Get notified when new Form 4 filings are submitted
| $14.40 |
| Discretionary |
| Jun 19, 2017 | ATNX | $0 | Award | 400,000 | $N/A | Discretionary |
| Jun 19, 2017 | ATNX | $277.2K | Purchase | 25,200 | $11.00 | Discretionary |
| Jun 4, 2012 | CHTP | $10.5K | Purchase | 8,000 | $1.31 | Discretionary |
| Oct 3, 2008 | CHTP | $2.8K | Purchase | 1,000 | $2.76 | Discretionary |
| Sep 29, 2008 | CHTP | $6.0K | Purchase | 2,000 | $3.02 | Discretionary |